Skip to main content
    K

    Karyopharm Therapeutics Inc (KPTI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.02
    -0.02 (-56.50%)

    Market Cap: $394,660

    Last updated: Nov 10, 2026 at 7:59 PM ET

    Karyopharm Therapeutics Inc (KPTI) Stock Chart

    Updated Nov 10, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Karyopharm Therapeutics (KPTI) has a latest price of $0.02 on Nov 10, 2026, 99.8% below its 52-week high of $10.99. Its price fell 88.6% over the 12 months through Oct 2026. The month-end price fell 99.4% over the 10 years through Oct 2026, a compound annual decline of 39.9%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $330.58 in Apr 2020 and its lowest $0.66 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart KPTI with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KPTI.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 99.1%, and over 6 months it fell 99.8%. The month-end price fell 94.9% over the 3 years through Oct 2026, a compound annual decline of 63.0%.

    PeriodChange
    1 month-96.6%
    3 months-99.1%
    6 months-99.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    1 year-88.6%-88.6%
    3 years-94.9%-63.0%
    5 years-99.2%-61.8%
    10 years-99.4%-39.9%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 104.6%, and its weakest was 2023, when it fell 74.6%.

    YearCloseChange
    2026 through Oct 2026$0.66-91.0%
    2025$7.36-27.4%
    2024$10.14-21.8%
    2023$12.97-74.6%
    2022$50.97-47.1%
    2021$96.40-58.5%
    2020$232.08-19.2%
    2019$287.41+104.6%
    2018$140.48-2.4%
    2017$143.93+2.1%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 98.2% below its 50-day average of $0.96 and 99.7% below its 200-day average of $5.81.

    MeasureValuePrice vs
    Latest price (Nov 10, 2026)$0.02
    52-week high$10.99-99.8%
    52-week low$0.02+2.4%
    50-day average$0.96-98.2%
    200-day average$5.81-99.7%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 99.9%.

    MeasureValue
    1-year beta1.07
    Largest fall, 1 year-99.8%
    Largest fall, 3 years-99.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About KPTI

    What is KPTI's 1-year price change?

    Karyopharm Therapeutics's price fell 88.6% over the 12 months through Oct 2026.

    What is KPTI's 5-year price change?

    Karyopharm Therapeutics's month-end price fell 99.2% over the 5 years through Oct 2026, a compound annual decline of 61.8%. These figures leave out dividends.

    What is KPTI's 52-week high and low?

    Karyopharm Therapeutics's 52-week high is $10.99 and its 52-week low is $0.02. Its latest price of $0.02 on Nov 10, 2026 is 99.8% below the high.

    What is KPTI's beta?

    Karyopharm Therapeutics's 1-year beta against the S&P 500 is 1.07, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 99.8%.

    Is the KPTI chart free?

    Yes. Advanced Charting for KPTI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.